Literature DB >> 9871492

Locally infused taurine, GABA and homotaurine alter differently the striatal extracellular concentrations of dopamine and its metabolites in rats.

M Ruotsalainen1, M Majasaari, J Salimäki, L Ahtee.   

Abstract

We studied in vivo the effects of locally infused taurine (50, 150, and 450 mM) on the striatal dopamine and its metabolites in comparison with those of GABA and homotaurine, a GABAA receptor agonist, in freely moving rats. The extracellular dopamine concentration was elevated maximally 2.5-, 2- and 4-fold by taurine, GABA and homotaurine, respectively. At 150 mM concentration, at which the maximum effects occurred, homotaurine increased the extracellular dopamine more than taurine or GABA. When taurine and GABA were infused simultaneously with tetrodotoxin the output of dopamine did not differ from that in the presence of tetrodotoxin alone. In comparison, tetrodotoxin did not inhibit the increase in extracellular dopamine caused by homotaurine. Furthermore, omission of calcium from the perfusion fluid inhibited the increase of extracellular dopamine caused by GABA. However, it did not block the increase of dopamine caused by taurine or homotaurine. The present study suggests that the effects of intrastriatal taurine, GABA and homotaurine on the striatal extracellular dopamine differ. Thus, these amino acids seem to affect the striatal dopaminergic neurons via more than one mechanism.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9871492     DOI: 10.1007/bf01345285

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  4 in total

1.  Toxic effects of cadmium on GABA and taurine content in different brain areas of adult male rats.

Authors:  A Lafuente; A González-Carracedo; T Cabaleiro; A Romero; A I Esquifino
Journal:  J Physiol Biochem       Date:  2005-09       Impact factor: 4.158

2.  The effects of systemically administered taurine and N-pivaloyltaurine on striatal extracellular dopamine and taurine in freely moving rats.

Authors:  J Salimäki; G Scriba; T P Piepponen; N Rautolahti; L Ahtee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-07-26       Impact factor: 3.000

Review 3.  Taurine and its analogs in neurological disorders: Focus on therapeutic potential and molecular mechanisms.

Authors:  Md Jakaria; Shofiul Azam; Md Ezazul Haque; Song-Hee Jo; Md Sahab Uddin; In-Su Kim; Dong-Kug Choi
Journal:  Redox Biol       Date:  2019-05-21       Impact factor: 11.799

4.  Advances in drug design based on the amino Acid approach: taurine analogues for the treatment of CNS diseases.

Authors:  Man Chin Chung; Pedro Malatesta; Priscila Longhin Bosquesi; Paulo Renato Yamasaki; Jean Leandro Dos Santos; Ednir Oliveira Vizioli
Journal:  Pharmaceuticals (Basel)       Date:  2012-10-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.